{"id":"https://openalex.org/W7219896785","doi":"https://doi.org/10.3389/fonc.2026.2002791","title":"Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response","display_name":"Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response","publication_year":2026,"publication_date":"2026-10-05","ids":{"openalex":"https://openalex.org/W7219896785","doi":"https://doi.org/10.3389/fonc.2026.2002791","pmid":"https://pubmed.ncbi.nlm.nih.gov/42898281","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13677474"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.2002791","doi":"https://doi.org/10.3389/fonc.2026.2002791","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.2002791","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2002791/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2002791/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153575828","display_name":"Jacobo Rogado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Jacobo Rogado","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario de La Princesa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario de La Princesa","institution_ids":["https://openalex.org/I4210130498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027916507","display_name":"Elisabet Gonz\u00e1lez-Del Portillo","orcid":"https://orcid.org/0000-0002-0758-8156","observed_orcids":["https://orcid.org/0000-0002-0758-8156"]},"institutions":[{"id":"https://openalex.org/I4210101178","display_name":"Hospital Universitario Rey Juan Carlos","ror":"https://ror.org/019gdfm13","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101178"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Elisabet Gonz\u00e1lez del Portillo","raw_affiliation_strings":["Department of Radiation Oncology, Hospital Universitario Rey Juan Carlos"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Hospital Universitario Rey Juan Carlos","institution_ids":["https://openalex.org/I4210101178"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108553972","display_name":"Diego Elia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265188","display_name":"Hospital Universitario General de Villalba","ror":"https://ror.org/043n53y14","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4405265188"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Diego Casado El\u00eda","raw_affiliation_strings":["Department of Medical Oncology, Hospital General de Villalba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital General de Villalba","institution_ids":["https://openalex.org/I4405265188"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5137125454","display_name":"Jaime Rubio Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jaime Rubio-Perez","raw_affiliation_strings":["Department of Medicine, Memorial Sloan Kettering Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan Kettering Cancer Center","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5027916507","https://openalex.org/A5108553972","https://openalex.org/A5137125454","https://openalex.org/A5153575828"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210101178","https://openalex.org/I4210130498","https://openalex.org/I4405265188"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"2002791","last_page":"2002791"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/immunotherapy-response","display_name":"immunotherapy response","score":0.5910000205039978},{"id":"https://openalex.org/keywords/noninvasive-biomarkers","display_name":"non-invasive biomarkers","score":0.8320000171661377},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.9959999918937683},{"id":"https://openalex.org/keywords/multi-omics-profiling","display_name":"multi-omics profiling","score":0.9419999718666077},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9129999876022339},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":1.0},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8370000123977661},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.6658999919891357},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6553999781608582},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6467000246047974},{"id":"https://openalex.org/C187191949","wikidata":"https://www.wikidata.org/wiki/Q1138496","display_name":"Profiling (computer programming)","level":2,"score":0.6237000226974487},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4814000129699707},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.4036000072956085},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.361299991607666},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.35370001196861267},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3292999863624573},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.28200000524520874},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.27070000767707825},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.266400009393692},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.25690001249313354}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.2002791","doi":"https://doi.org/10.3389/fonc.2026.2002791","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.2002791","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2002791/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13677474","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677474/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13677474/pdf/fonc-16-2002791.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:42898281","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42898281","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Editorial"},{"id":"pmh:oai:doaj.org/article:ac4f7fc7aeb243b39e317dd531310498","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/ac4f7fc7aeb243b39e317dd531310498","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.2002791","doi":"https://doi.org/10.3389/fonc.2026.2002791","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.2002791","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2002791/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7219896785.pdf","grobid_xml":"https://content.openalex.org/works/W7219896785.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2527905628","https://openalex.org/W2797675588","https://openalex.org/W4282600306","https://openalex.org/W4405673774"],"related_works":["https://openalex.org/W3176297088","https://openalex.org/W3186720652","https://openalex.org/W3112122563","https://openalex.org/W3136699543","https://openalex.org/W4281996888","https://openalex.org/W2605040673","https://openalex.org/W2985170860","https://openalex.org/W3135979839","https://openalex.org/W7215097157","https://openalex.org/W3121635006"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitors":[2],"(ICIs)":[3],"have":[4],"changed":[5],"the":[6,38],"treatment":[7,25],"of":[8,22,37],"non-small":[9],"cell":[10],"lung":[11],"cancer":[12],"(NSCLC),":[13],"producing":[14],"24":[15],"durable":[16],"disease":[17],"control":[18],"in":[19],"a":[20,66],"proportion":[21],"patients.":[23],"However,":[24],"selection":[26],"still":[27],"depends":[28],"largely":[29],"on":[30,65],"25":[31],"biomarkers":[32],"that":[33],"capture":[34],"only":[35],"part":[36],"tumor-immune":[39],"interaction.":[40],"Programmed":[41],"death-ligand":[42],"1":[43],"(PD-L1)":[44],"26":[45],"expression":[46],"and":[47,57,63],"tumor":[48],"mutational":[49],"burden":[50],"(TMB)":[51],"remain":[52],"clinically":[53],"useful,":[54],"but":[55],"spatial":[56],"temporal":[58],"heterogeneity,":[59],"27":[60],"assay":[61],"variability,":[62],"reliance":[64],"single":[67],"tissue":[68],"specimen":[69],"limit":[70],"their":[71],"predictive":[72],"accuracy":[73],"(":[74]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-05T00:00:00"}